Brief: Alzinova Gets Fast Track Designation from US FDA
06/10/2025 07:14
Oct 6 (Reuters) - Alzinova AB ALZ.ST: SAID ON SATURDAY THAT U.S. FDA HAS GRANTED FAST TRACK DESIGNATION FOR CO’S VACCINE CANDIDATE ALZ-101 IN ALZHEIMER’S DISEASE Source text for Workspace: nMFN7Yr2QN Further company coverage: ALZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alzinova AB
See all newsBrief: Alzinova's Board Resolves On Directed Issue Of Units
Brief: Alzinova Announces Preliminary Outcome Of The Rights Issue
Brief: Alzinova Broadens Shareholder Base With New Investor
Brief: Alzinova Resolves On Rights Issue Of SEK 51 Mln
Brief: Alzinova Q2 Loss After Financial Items At SEK 5.4 Million